Medi Caps Intrinsic Value
Medi Caps (MEDICAPQ) median intrinsic value is ₹35.71 from 3 valuation models (range ₹25–₹68), vs current price ₹27.01 — +32.2% upside (Trading Below Calculated Value), margin of safety 24.4%. For current market price and key ratios, visit Medi Caps stock price NSE.
MEDICAPQ Valuation Methods Summary — DCF, Graham Number & P/E
Medi Caps intrinsic value across 3 models vs current price ₹27.01 — upside/downside and value range per method. Browse MEDICAPQ cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹67.53 | ₹60.78 - ₹74.28 | +150.0% | Book Value/Share: ₹93.08, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹24.62 | ₹22.16 - ₹27.08 | -8.8% | Revenue/Share: ₹12.31, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹35.71 | ₹28.57 - ₹42.85 | +32.2% | CF Growth: 5.0%, Discount: 15% |
MEDICAPQ Intrinsic Value vs Market Price — All Valuation Models
Medi Caps fair value range ₹25–₹68 vs current market price ₹27.01 across 3 valuation models. Also explore Medi Caps share price performance to track price trends across different timeframes.
MEDICAPQ Intrinsic Value Analysis — Undervalued or Overvalued?
Medi Caps median intrinsic value ₹35.71, current price ₹27.01 — Trading Below Calculated Value by 32.2%, margin of safety 24.4%.
What is the intrinsic value of MEDICAPQ?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Medi Caps (MEDICAPQ) is ₹35.71 (median value). With the current market price of ₹27.01, this represents a +32.2% variance from our estimated fair value.
The valuation range spans from ₹24.62 to ₹67.53, indicating ₹24.62 - ₹67.53.
Is MEDICAPQ undervalued or overvalued?
Based on our multi-method analysis, Medi Caps (MEDICAPQ) appears to be trading below calculated value by approximately 32.2%.
MEDICAPQ Financial Health — Key Ratios vs Industry Benchmarks
Medi Caps financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 53.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -6.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -145.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.13x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
MEDICAPQ Cash Flow Quality — Operating & Free Cash Flow
Medi Caps operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹5 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹7 Cr | ₹3 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-6 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹7 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹15 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |